XML 164 R121.htm IDEA: XBRL DOCUMENT v3.25.4
Share-Based Payments - Share-based Compensation Expense Included in Consolidation Statements of Income (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]      
Subtotal $ 303.5 $ 352.7 $ 668.4
Capitalized share-based compensation costs (12.4) (10.3) (10.2)
Share-based compensation expense included in total cost and expense 291.1 342.4 658.2
Income tax effect (57.0) (63.4) (132.6)
Research and development      
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]      
Share-based compensation expense 115.7 154.1 296.7
Selling, general and administrative      
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]      
Share-based compensation expense 187.8 198.6 371.7
Share-based compensation expense included in net income attributable to Biogen Inc.      
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]      
Share-based compensation expense $ 234.1 $ 279.0 $ 525.6